Retinaldehyde is a substrate for human aldo–keto reductases of the 1C subfamily
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Retinaldehyde is a substrate for human aldo–keto reductases of the 1C subfamily
Authors
Keywords
-
Journal
BIOCHEMICAL JOURNAL
Volume 440, Issue 3, Pages 335-347
Publisher
Portland Press Ltd.
Online
2011-08-22
DOI
10.1042/bj20111286
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Retinoids, Retinoic Acid Receptors, and Cancer
- (2011) Xiao-Han Tang et al. Annual Review of Pathology-Mechanisms of Disease
- From carrot to clinic: an overview of the retinoic acid signaling pathway
- (2010) Maria Theodosiou et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Identification of 9-cis-retinoic acid as a pancreas-specific autacoid that attenuates glucose-stimulated insulin secretion
- (2010) M. A. Kane et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Steroid Hormone Transforming Aldo-Keto Reductases and Cancer
- (2009) Trevor M. Penning et al. Annals of the New York Academy of Sciences
- Induction of neoplastic transformation by ectopic expression of human aldo-keto reductase 1C isoforms in NIH3T3 cells
- (2009) Chia-Wen Chien et al. CARCINOGENESIS
- Aldo-keto reductase 1C subfamily genes in skin are UV-inducible: possible role in keratinocytes survival
- (2009) Yarí E. Marín et al. EXPERIMENTAL DERMATOLOGY
- The endogenous retinoid metaboliteS-4-oxo-9-cis-13,14-dihydro-retinoic acid activates retinoic acid receptor signalling bothin vitroandin vivo
- (2009) Jan P. Schuchardt et al. FEBS Journal
- Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer
- (2009) Michael C. Byrns et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance
- (2009) Zachary W. Veitch et al. Pharmacogenetics and Genomics
- Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia
- (2009) Farhat L. Khanim et al. PLoS One
- Medium- and short-chain dehydrogenase/reductase gene and protein families
- (2008) X. Parés et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Aldo-keto reductases from the AKR1B subfamily: Retinoid specificity and control of cellular retinoic acid levels
- (2008) F. Xavier Ruiz et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dΔ12,14,PGJ2
- (2008) R E Hayden et al. LEUKEMIA
- AKR1C2 and AKR1C3 mediated prostaglandin D2 metabolism augments the PI3K/Akt proliferative signaling pathway in human prostate cancer cells
- (2008) Shaobin Wang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies
- (2007) Michael C. Byrns et al. BIOCHEMICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started